Speaker(s): 

Laurie T. Wallace, BS, RRT-NPS, Staff Member, Geisinger - has nothing to disclose.

Moderator(s): 

N/A

Learning Objectives: 

At the conclusion of this session, the participant should be able to: 

• Discuss the pathophysiology of patients with COPD and inhalation device considerations.
• Review the updates on recently approved and newly marketed nebulized treatments, nebulized treatments in development and technological advances in nebulizer devices.
• Discuss the current applications of nebulized therapy in patients with COPD.

Disclosure of Relevant Financial Relationships with/without Commercial Interests:

The Planning Committee consisting of Ronald Wong, MD, Katie Ritz, RRT, Mark Williams, RN, Katelyn Green have no identified disclosures. 

CE Committee Member/Content Reviewers have nothing to disclose. 

Any/All relevant financial relationships have been mitigated. 

Content Disclosure: 

This presentation/content is HIPPA compliant. 

Commerical Support for this Session

None.